Profile data is unavailable for this security.
About the company
Vaccinex, Inc. is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including neurodegenerative diseases, cancer, and autoimmune disorders. Its lead product candidate, pepinemab, is in clinical development for the treatment of Alzheimer’s disease, head and neck, pancreatic and breast cancer. Its lead platform technologies include SEMA4D antibody platform and ActivMAb antibody discovery platform. SEMA4D antibody platform is the application of its knowledge of SEMA4D biology to develop pepinemab for the treatment of various diseases and conditions, including cancer. ActivMAb antibody discovery platform is a human antibody discovery platform based on a method for expressing multipass membrane proteins, as well as large and diverse libraries of high affinity, full-length human monoclonal antibodies on the surface of mammalian pox viruses.
- Revenue in USD (TTM)570.00k
- Net income in USD-20.25m
- Incorporated2001
- Employees37.00
- LocationVaccinex Inc1895 Mount Hope AveROCHESTER 14620-4540United StatesUSA
- Phone+1 (585) 271-2700
- Fax+1 (585) 271-2765
- Websitehttps://www.vaccinex.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Longeveron Inc | 709.00k | -22.21m | 8.13m | 23.00 | -- | 3.02 | -- | 11.46 | -10.18 | -10.18 | 0.3262 | 0.4245 | 0.0359 | -- | 4.31 | 30,826.09 | -108.45 | -63.15 | -139.35 | -75.68 | 31.17 | 33.70 | -3,020.17 | -441.02 | -- | -- | 0.00 | -- | -41.98 | -19.78 | -17.92 | -- | 26.80 | -- |
| CV Sciences Inc | 16.00m | 3.10m | 8.16m | 42.00 | 2.42 | 2.78 | 2.45 | 0.51 | 0.0206 | 0.0206 | 0.104 | 0.018 | 1.46 | 1.46 | 26.74 | 381,047.60 | 28.28 | -43.42 | 247.47 | -77.75 | 44.27 | 51.81 | 19.38 | -45.68 | 0.3733 | 13.68 | 0.0805 | -- | -1.24 | -19.80 | 133.96 | -20.87 | -- | -- |
| Entero Therapeutics Inc | 0.00 | -16.10m | 8.20m | 15.00 | -- | 1.29 | -- | -- | -88.75 | -88.75 | 0.00 | 2.31 | 0.00 | -- | -- | 0.00 | -256.35 | -295.92 | -471.06 | -1,599.51 | -- | -- | -- | -- | -- | -790.91 | 0.1454 | -- | -- | -- | -7.55 | -- | -- | -- |
| Odonate Inc | 0.00 | -102.07m | 8.33m | 137.00 | -- | 307.35 | -- | -- | -13.59 | -13.59 | 0.00 | 9.27 | 0.00 | -- | -- | 0.00 | -66.98 | -58.36 | -83.00 | -65.14 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -12.99 | -- | -- | -- |
| Viaderma Inc | 17.80m | 2.31m | 8.60m | 75.00 | 0.0004 | 0.00003 | 1.59 | 0.483 | 16.84 | 16.84 | 129.62 | 255.59 | 0.4126 | 24.69 | 1.21 | 237,331.30 | 5.36 | -- | 6.53 | -- | 28.90 | -- | 12.99 | -- | 2.07 | 5.66 | 0.1718 | -- | -29.15 | -- | -40.70 | -- | -- | -- |
| Energy Finders Inc | 4.06m | -2.92m | 8.61m | 46.00 | -- | -- | -- | 2.12 | -0.272 | -0.272 | 1.52 | 3.04 | -- | -- | -- | 88,304.35 | -- | -- | -- | -- | 27.45 | -- | -71.79 | -- | 0.6706 | -12.57 | 0.564 | -- | -- | -- | -- | -- | -- | -- |
| Vaccinex Inc | 570.00k | -20.25m | 8.78m | 37.00 | -- | -- | -- | 15.40 | -63.98 | -63.98 | 1.23 | -2.59 | 0.0982 | -- | 1.00 | 15,405.41 | -348.91 | -262.29 | -1,283.74 | -- | -- | -- | -3,552.81 | -4,257.17 | -- | -59.75 | -- | -- | 107.27 | -4.67 | -2.20 | -- | -22.20 | -- |
| Protext Mobility Inc | 750.00 | -2.21m | 8.79m | 4.00 | -- | -- | -- | 11,721.63 | -0.4692 | -0.4692 | 0.00001 | -0.0102 | 0.0405 | -- | -- | -- | -9,400.97 | -1,587.94 | -- | -- | 86.67 | -530.19 | -232,392.00 | -17,498.83 | 0.0002 | -1.36 | -- | -- | -93.98 | -63.09 | 27.35 | -- | -- | -- |
| BioRestorative Therapies Inc | 145.80k | -14.42m | 8.80m | 11.00 | -- | 0.5305 | -- | 60.36 | -3.54 | -3.54 | 0.0346 | 2.45 | 0.01 | -- | 8.26 | 13,254.55 | -99.26 | -199.86 | -104.68 | -334.04 | -- | -- | -9,887.16 | -19,887.03 | -- | -- | 0.00 | -- | 21.70 | 5.61 | 22.06 | -- | 67.77 | -- |
| eFFECTOR Therapeutics Inc | 0.00 | -34.63m | 9.13m | 14.00 | -- | 9.15 | -- | -- | -13.31 | -13.31 | 0.00 | 0.2119 | 0.00 | -- | -- | 0.00 | -141.18 | -- | -- | -- | -- | -- | -- | -- | -- | -17.12 | 0.9581 | -- | -100.00 | -- | -58.00 | -- | -- | -- |
| Notable Labs Ltd | 310.00k | -11.26m | 9.20m | 16.00 | -- | 0.6086 | -- | 29.67 | -3.08 | -3.08 | 0.0939 | 1.68 | 0.0126 | -- | -- | 19,375.00 | -45.79 | -52.02 | -56.70 | -62.09 | 36.45 | 60.19 | -3,633.55 | -3,636.93 | -- | -- | 0.0221 | -- | -52.89 | -11.93 | 65.13 | -- | -50.69 | -- |
| Ayala Pharmaceuticals Inc | 13.00k | -48.07m | 9.38m | 20.00 | -- | -- | -- | 721.49 | -7.46 | -7.46 | 0.0022 | -2.06 | -- | -- | -- | 650.00 | -- | -- | -- | -- | 0.00 | -- | -369,784.60 | -- | -- | -2.31 | -- | -- | -- | -- | -- | -- | -- | -- |
| Universe Pharmaceuticals Inc | 32.31m | -6.16m | 9.44m | 225.00 | -- | 0.2375 | -- | 0.2923 | -1.70 | -1.70 | 8.91 | 10.91 | 0.5727 | 7.93 | 2.50 | 143,594.40 | -10.92 | 5.31 | -14.34 | 7.07 | 31.93 | 46.26 | -19.08 | 6.25 | 2.43 | -28.05 | 0.1218 | 0.00 | -19.52 | 2.53 | 29.46 | -- | -21.17 | -- |
| Molecular Templates Inc | 31.76m | -18.40m | 9.55m | 62.00 | -- | 1.33 | -- | 0.3006 | -4.36 | -4.36 | 5.98 | 1.09 | 0.6014 | -- | 19.55 | 512,306.40 | -34.83 | -51.78 | -54.80 | -73.14 | -- | -- | -57.92 | -228.33 | -- | -52.11 | 0.00 | -- | 190.10 | 33.96 | 91.24 | -- | -48.87 | -- |
| Weed Inc | 0.00 | -31.55k | 9.63m | 2.00 | -- | 37.73 | 337.48 | -- | -0.0002 | -0.0002 | 0.00 | 0.0021 | 0.00 | -- | -- | 0.00 | -2.49 | -385.93 | -14.84 | -822.37 | -- | -- | -- | -- | -- | -16.98 | 0.3488 | -- | -- | -- | 97.93 | -- | -59.13 | -- |
Data as of May 17 2024. Currency figures normalised to Vaccinex Inc's reporting currency: US Dollar USD
19.52%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Point72 Asset Management LPas of 06 Feb 2024 | 116.55k | 9.99% |
| AIGH Capital Management LLCas of 31 Dec 2023 | 58.36k | 5.00% |
| Worth Venture Partners LLCas of 31 Dec 2023 | 46.72k | 4.01% |
| Renaissance Technologies LLCas of 31 Dec 2023 | 2.29k | 0.20% |
| Two Sigma Investments LPas of 31 Dec 2023 | 1.15k | 0.10% |
| Geode Capital Management LLCas of 31 Dec 2023 | 1.15k | 0.10% |
| XTX Markets LLCas of 31 Dec 2023 | 838.00 | 0.07% |
| Tower Research Capital LLCas of 31 Dec 2023 | 475.00 | 0.04% |
| Group One Trading LPas of 31 Mar 2024 | 67.00 | 0.01% |
| Osaic Wealth, Inc. (Investment Management)as of 31 Mar 2024 | 53.00 | 0.01% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
